What does TELEFLEX MEDICAL do?

TELEFLEX MEDICAL is a wholesaler in Brussel. Private Limited, started on 30 May 1960, 1 establishment.

What is the address of TELEFLEX MEDICAL?

The registered office of TELEFLEX MEDICAL is located at Marnixlaan 23, 1000 Brussel.

Is TELEFLEX MEDICAL still active?

Yes. According to the CBE (29 October 2026) TELEFLEX MEDICAL is active, legal situation “Normale toestand”, started on 30 May 1960.

Is TELEFLEX MEDICAL registered on Peppol?

Yes, TELEFLEX MEDICAL is registered on the Peppol network with ID 0208:0401993536.

What is the enterprise number of TELEFLEX MEDICAL?

The enterprise number of TELEFLEX MEDICAL is BE0401993536.

When was TELEFLEX MEDICAL founded?

TELEFLEX MEDICAL was founded on 30 May 1960.

Who are the directors of TELEFLEX MEDICAL?

According to the 2025 annual accounts, the directors of TELEFLEX MEDICAL are: Jan Breugelmans, James Matthew.

Is TELEFLEX MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 May 1960; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did TELEFLEX MEDICAL make in 2025?

TELEFLEX MEDICAL posted a profit after taxes of € 435,178 in financial year 2025.

What is the revenue of TELEFLEX MEDICAL?

In its most recent annual accounts (2025), TELEFLEX MEDICAL reported revenue of € 18,660,014.

How much does an employee at TELEFLEX MEDICAL earn?

The average wage cost per full-time employee at TELEFLEX MEDICAL was € 148,200 in 2025: staff costs of € 2.5 million for 16.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does TELEFLEX MEDICAL have?

According to the 2025 annual accounts, TELEFLEX MEDICAL has 16.8 full-time equivalents (FTE).

TELEFLEX MEDICAL (Private Limited) - Brussel

Dossier TELEFLEX MEDICAL, printed on 29 October 2026 from databakkes.be/en/0401993536/teleflex-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

56 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

TELEFLEX MEDICAL from Brussel, company number BE0401993536, closed financial year 2025 with a result of € 435,178 after tax. For that financial year TELEFLEX MEDICAL recorded revenue of € 18.7 million and equity of € 3.6 million. Compared with financial year 2024, the result moved from € 698,641 to € 435,178. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What it is worth Growing

€ 3.6 million

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 435,178

▼ 38% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.5 million

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 2.9 million.

People and assets in 2025

Full-time equivalents

16.8

▲ 1.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 846,122 in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 2.5 million

▲ 23% vs 2024

€ 148,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4 million

▲ 97% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 90 days on average.

Taxes and wages

€ 927,319

▲ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 17,242,943 Revenue 2022: € 17,242,943 First fiscal year in the series	€ 17,670,069 Revenue 2023: € 17,670,069 ▲ 2% vs 2022 (€ 17,242,943) Favourable step	€ 18,300,462 Revenue 2024: € 18,300,462 ▲ 4% vs 2023 (€ 17,670,069) Favourable step	€ 18,660,014 Revenue 2025: € 18,660,014 ▲ 2% vs 2024 (€ 18,300,462) Favourable step	▲ 2%
Profit after taxes	€ 680,820 Profit after taxes 2022: € 680,820 First fiscal year in the series	€ 675,302 Profit after taxes 2023: € 675,302 ▼ 1% vs 2022 (€ 680,820) Unfavourable step	€ 698,641 Profit after taxes 2024: € 698,641 ▲ 3% vs 2023 (€ 675,302) Favourable step	€ 435,178 Profit after taxes 2025: € 435,178 ▼ 38% vs 2024 (€ 698,641) Unfavourable step	▼ 38%
Equity	€ 8,321,580 Equity 2022: € 8,321,580 First fiscal year in the series	€ 2,496,882 Equity 2023: € 2,496,882 ▼ 70% vs 2022 (€ 8,321,580) Unfavourable step	€ 3,195,524 Equity 2024: € 3,195,524 ▲ 28% vs 2023 (€ 2,496,882) Favourable step	€ 3,630,702 Equity 2025: € 3,630,702 ▲ 14% vs 2024 (€ 3,195,524) Favourable step	▲ 14%
Total debts	€ 2,357,679 Total debts 2022: € 2,357,679 First fiscal year in the series	€ 9,191,839 Total debts 2023: € 9,191,839 ▲ 290% vs 2022 (€ 2,357,679) Unfavourable step	€ 3,140,678 Total debts 2024: € 3,140,678 ▼ 66% vs 2023 (€ 9,191,839) Favourable step	€ 5,244,738 Total debts 2025: € 5,244,738 ▲ 67% vs 2024 (€ 3,140,678) Unfavourable step	▲ 67%
Cash	€ 3,751,393 Cash 2022: € 3,751,393 First fiscal year in the series	€ 7,017,406 Cash 2023: € 7,017,406 ▲ 87% vs 2022 (€ 3,751,393) Favourable step	€ 1,739,315 Cash 2024: € 1,739,315 ▼ 75% vs 2023 (€ 7,017,406) Unfavourable step	€ 1,466,532 Cash 2025: € 1,466,532 ▼ 16% vs 2024 (€ 1,739,315) Unfavourable step	▼ 16%
Retained profit	€ 7,614,380 Retained profit 2022: € 7,614,380 First fiscal year in the series	€ 1,789,682 Retained profit 2023: € 1,789,682 ▼ 76% vs 2022 (€ 7,614,380) Unfavourable step	€ 2,488,324 Retained profit 2024: € 2,488,324 ▲ 39% vs 2023 (€ 1,789,682) Favourable step	€ 2,923,502 Retained profit 2025: € 2,923,502 ▲ 17% vs 2024 (€ 2,488,324) Favourable step	▲ 17%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 6,500,000 Dividend 2023: € 6,500,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 6,500,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 10,679,259 Balance sheet total 2022: € 10,679,259 First fiscal year in the series	€ 11,694,414 Balance sheet total 2023: € 11,694,414 ▲ 10% vs 2022 (€ 10,679,259) Unchanged	€ 6,341,228 Balance sheet total 2024: € 6,341,228 ▼ 46% vs 2023 (€ 11,694,414) Unchanged	€ 8,884,506 Balance sheet total 2025: € 8,884,506 ▲ 40% vs 2024 (€ 6,341,228) Unchanged	▲ 40%
Employees (FTE)	16.8 Employees (FTE) 2022: 16.8 First fiscal year in the series	14.5 Employees (FTE) 2023: 14.5 ▼ 2.3 vs 2022 (16.8) Unchanged	15.6 Employees (FTE) 2024: 15.6 ▲ 1.1 vs 2023 (14.5) Unchanged	16.8 Employees (FTE) 2025: 16.8 ▲ 1.2 vs 2024 (15.6) Unchanged	▲ 1.2

Key figures of TELEFLEX MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TELEFLEX MEDICAL?

What happened at TELEFLEX MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 8, 2026 New annual accounts for financial year 2025: profit of € 435,178 (▼ 38% vs 2024). Source: NBB ↗
2021 James Matthew became a director. NBB
2018 Jan Breugelmans became a director. NBB
Jul 1, 1960 New establishment in Brussel. KBO
May 30, 1960 Start of the company according to the CBE. KBO

In short

From € 680,820 profit in 2022 to € 435,178 profit in 2025.

Paid € 979,421 in corporate taxes since 2022.

Best year ever: 2024, with € 698,641 profit.

Paid out € 6.5 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Jan Breugelmans

James Matthew

TELEFLEX MEDICAL

VI Belgium 100%

Behind TELEFLEX MEDICAL are Jan Breugelmans and James Matthew. It owns 100% of VI Belgium itself.

Directors

According to the 2025 annual accounts

Jan Breugelmans

Director

Also active at: VI Belgium

since 2018

James Matthew

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Marnixlaan 23

1000 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 56 companies are registered at this address.

All companies at this address →

CUSHMAN & WAKEFIELD WINSSINGER TIE LEUNG

€ 218,925 revenue · 2024

Paardekooper België

Sunparks Oostduinkerke

€ 3.9 million revenue · 2025

CUSHMAN & WAKEFIELD BELGIUM

€ 14.4 million revenue · 2024

ADVANCED MICRO DEVICES BELGIUM

€ 1.5 million gross margin · 2025

+51 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0401.993.536

VAT number

BE 0401.993.536

Registered office

Marnixlaan 23, 1000 Brussel

Names & denominations

TELEFLEX MEDICAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 May 1960

Peppol

Active · Active since 27 Feb 2026

Contact

[email protected]

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

TELEFLEX MEDICAL

Warning lights

Financials

What happened to TELEFLEX MEDICAL?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions